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ABSTRACT !
Mycobacterium tuberculosis, the causative agent of tuberculosis, is estimated to 
infect approximately one-third of the world’s population and is responsible for 
around 2 million deaths per year. The disease is endemic in South Africa which has 
one of the world’s highest tuberculosis incidence and death rates. The M. 
tuberculosis Beijing genotype are characterised by having an enhanced virulence 
capability over other M. tuberculosis strains and are the predominant strain 
observed in the Western Cape of South Africa.  DNA methylation is a largely 
untapped area of research in M.tuberculosis and has been  poorly described in the 
literature  especially  given its connection to virulence despite it being well 
characterised along with its role in virulence in other pathogenic bacteria such as 
E.coli. The overall aim was to characterise a global DNA methylation profile for 
two  M. tuberculosis Beijing strains, hyper-virulent and hypo-virulent, using single 
molecule real time sequencing data technology. Moreover, to determine if adenine 
methylation in promoter regions has a possible functional role. 
 
This study identified and characterised the DNA methylation profile at the single 
nucleotide resolution in these strains using Pacific Biosciences single molecule real 
time sequencing data. A computational approach was used to discern DNA 
methylation patterns between the hyper and hypo-virulent strains with a view of 
understanding virulence in the hyper-virulent strain. Methylated motifs, which 
belong to known Restriction Modification (RM) systems of the H37Rv reference 
genome were also identified. N6-methyladenine (m6A) and N4-methlycytosine 
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(m4C) loci were identified in both strains. m6A were idenitified in both strains 
occuring within the following sequence motifs CACGCAG (Type II RM system), 
GATNNNNRTAC/GTAYNNNNATC (Type I RM system), while the 
CTGGAGGA motif was found to be uniquley methylated in the hyper-virulent 
strain.  
Interestingly, the CACGCAG motif was significantly methylated (p = 9.9 x10 -63) at 
a higher proportion in intergenic regions (~70%) as opposed to genic regions in 
both the hyper-virulent and hypo-virulent strains suggesting a role in gene 
regulation. There appeared to be a higher proportion of  m6A occuring in intergenic 
regions compared to within genes for hyper-virulent (61%) and hypo-virulent 
(62%) strains. The genic proportion revealed that 35% of total m6A occurred 
uniquely within genes for the hyper-virulent strain while 27.9% for uniquely 
methylated genes in hypo-virulent strain.  
 
A functional enrichment of the genes that were uniquely methylated in the hypo-
virulent and hyper-virulent strains, revealed the following COG categories as 
significant: 1) Secondary metabolites biosynthesis, transport and catabolism was 
significant in the hyper-virulent strain (p = 0.006), 2) Energy production and 
conversion (p = 0.015) and 3) Cell wall/membrane/envelope biogenesis (p = 0.047) 
in the hypo-virulent strain. For the shared methylated genes between the two 
strains, no functional categories were statistically significant. 
 
The DNA methylation patterns revealed that the majority (79%) of the m6A loci 
were shared between the hyper- and hypo-virulent strains. Despite the high 
proportion of shared methylated regions between hyper-virulent and hypo-virulent 
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strains we still observe strain specific pathways and genes. Analysis of methylated 
promoter associated genes reveal that the functional categories significantly 
enriched uniquely to the hyper-virulent strain were GO categories ‘response to acid’ 
and ‘energy conversion’.  The enriched categories might suggest that these genes 
respond to stress conditions or adaptation to survival in the hyper-virulent strain.  
 
This is the first study to our knowledge that identified  and characerised m6A on a 
single nucleotide level using PacBio sequencing for M.tuberculosis. The DNA 
methylation analysis provides a starting point into understanding the role of DNA 
methylation and virulence strategies for M. tuberculosis. 
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CHAPTER 1: LITERATURE REVIEW 
1.1 The Mycobacterium tuberculosis genome 
1.1.1 Mycobacterium and the M. tuberculosis complex (MTC) 
 
Mycobacterium tuberculosis is a bacterium that belongs to the family 
Mycobacteriaceae, the suborder Corynebacterineae, the order Actinomycetales and 
the phylum Actinobacteria. Members of the suborder Corynebacterineae are acid-
fast, gram-positive, high-GC bacteria, with a thick peptidoglycan layer in their cell 
wall that encloses their cell membranes (Silhavy et al. 2010). Prominent pathogens 
in the Mycobacterium genus are the Mycobacterium tuberculosis Complex (MTC) 
cluster, which include both human and non-human pathogens. These are the M. 
tuberculosis, whose target host are the primates; M. bovis, which target cattle but 
may also infect other hosts including human; M. africanum, which is the primary 
cause of human tuberculosis in West Africa and M. microti, which is rare but 
traditionally infects voles. Two additional species have recently been added to the 
MTC complex, and these include M. canettii, which was isolated from a Somali-
born patient (van Soolingen et al. 1997) and M. caprae, a species that primarily 
targets goats (Cousins et al. 2003) 
 
Both biochemical and molecular genomics techniques have been used in the 
isolation and characterisation of the MTC pathogens, since members of this group 
are genetically closely related, and may be considered as a subspecies of  M. 
tuberculosis. Some of the widely applied classification techniques include: 1) DNA-
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DNA hybridization, with a sequence similarity threshold greater than 95%, 2) 
multiple-locus enzyme electrophoresis, 3) 16s ribosomal RNA gene sequencing and 
4) interrogation of the repetitive insertion sequence IS6110 and the direct repeat 
(DR) (van Soolingen et al. 1997). 
 
1.1.2 Tuberculosis pathogenesis in humans 
 
Tuberculosis is an infectious disease, which is caused by the pathogenic bacteria, 
Mycobacterium tuberculosis and affects the pulmonary system in humans and 
animals. It typically affects the  lungs (pulmonary TB) but can affect other sites as 
well (extrapulmonary TB). The M. tuberculosis pathogen was first discovered by 
Robert Koch in 1882, and communicated to the Berlin Society of Physiology as the 
aetiological agent for the disease tuberculosis (Cambau & Drancourt 2014). The 
World Health Organization (WHO), declared TB a global health emergency in 
1993, and estimates that there were 8.6 million incident cases of active TB disease 
globally in 2012 and 1.3 million deaths (WHO| Global Tuberculosis Report, 2013). 
Around a third of the human population is infected with TB and 90% of the cases 
remain latent. South Africa has the highest incidence rate in the world with 1000 
cases per 100 000 population in some regions of South Africa.  
 
Transmission of M. tuberculosis occurs when the human subject inhales droplets 
containing the bacilli. In the lung alveolar, macrophages engulf and kill the bacilli 
through phagocytosis, but those that survive are transported into the lung tissue 
where they remain within the macrophage structure. The pathogen engages in 
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different mechanisms to evade lysis, such as inhibiting the fusion of the phagosome 
with the lysosome. The presence of the bacilli in the phagosome leads to the 
formation of a granuloma as the immune system responds in an attempt to isolate 
the infected tissue. The most prominent cells in the fight against M. tuberculosis are 
the T cells, and particularly the Th1 effector CD4+ T cells, whose activation leads 
to the secretion of Interferon gamma (IFN-γ) and Tumor necrosis factor alpha 
(TNF-α). IFN-γ and TNF-α triggers the oxidative burst, which generates Nitric 
oxide (NO), as well as other reactive oxygen and nitrogen intermediates. However, 
the presence of these compounds in vivo only serves to control the bacillus as it fails 
to eradicate it (Kursar et al. 2007; Forrellad et al. 2013)  
 
Further exacerbating TB is the co-infection with Human Immuno-deficiency Virus 
(HIV). There are approximately 1.1 million HIV positive new TB cases in 2012 
globally of which 75 % of infected individuals live in  sub-Saharan Africa. 
Furthermore TB is the leading cause of death among HIV infected patients and it 
presents emerging cases of multi-drug resistant (MDR-TB) and extensively drug 
resistant TB (XDR-TB). (WHO| HIV-Associated Tuberculosis, 2013). 
 
1.1.3 Virulence of M. tuberculosis  !
M. tuberculosis does not have any classical virulence factors, such as pathogenicity 
islands or secretion of toxins that are prominent in other pathogenic bacteria 
(Forrellad et al. 2013). Currently, there are two models that are applied in 
quantifying TB virulence. These are the animal model, which uses non-human 
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primates and other subjects, and the cellular model that utilizes in vitro assay. When 
using animal subjects, colony forming units (CFU) of the M. tuberculosis bacilli, in 
the form of an aerosol, are administered intranasally to mimic natural infection 
(Smith 2003). Once infected, the different parameters is observed in the subject, 
such as its ability to cause secondary infections to induce extrapulmonary infection 
(Nicol & Wilkinson 2008). 
 
In virulence quantification using the cellular model, the focus is Mycobacterial 
infection in the macrophage, dendritic, alveolar and the cells of the adipose tissue. 
Once infection has been established, three measures can be taken to assess virulence 
and disease progression and include 1) observation based on fluorescent 
microscopy, 2) the ability to interfere phagosome maturation, and 3) analysis of the 
cytokine profiles, and primary Tumor Necrosis Factor alpha (TNFα), Interleukin 2 
(IL-2), Interleukin 12 (IL-12), and Interferon gamma (IFNγ) (Smith 2003). Despite 
having genetic similarity of 99% in M. tuberculosis strains (Brosch et al. 2002; 
Fleischmann et al. 2002) there are differences in virulence and immunogenicity in 
experimental infection models associated with certain strains.  However, a link has 
not been established between observed virulence phenotypes, and the molecular 
profile of any given strain (Coscolla & Gagneux 2010). 
 
Genomic variations, such as Single Nucleotide Polymorphisms (SNPs), have been 
observed in translating into phenotypic changes that confer drug resistance, and 
particularly in the Beijing strains (Ebrahimi Rad et al. 2003). Generally, strain-
specific virulence mechanisms in M. tuberculosis can be identified by first isolating 
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strains with similar clinical manifestations, followed by cellular assays for specific 
differentiating traits.  For example, strains that have been observed to cause 
infection as a cluster, implying recent disease transmission, tend to grow at a rapid 
rate than unique ones in a macrophage in vitro assay (Zhang et al. 1999; Nicol & 
Wilkinson 2008). 
 
1.1.4 The Beijing Genotype  
 
Of great interest in M. tuberculosis studies is the Beijing strain family, which 
belongs to the principal genetic  group 1 and was first described by (van Soolingen 
et al. 1995) as the dominant genotype of M. tuberculosis in South East Asia. Recent 
studies have demonstrated that it is one of the world’s most wide-spread M. 
tuberculosis genotype (Glynn et al. 2002). The Beijing strain family exhibits 
selective advantage over other lineages, and this is conferred through increased 
virulence and rate of transmission that has been demonstrated through in vitro 
assays and in vivo using animal models (Li et al. 2002; López et al. 2003; Manca et 
al. 2004). It is considered hyper-virulent (Parwati et al. 2010) and is associated with 
multi-drug resistance (Borrell & Gagneux 2011). A number of reports link the 
Beijing strains with extrapulmonary TB or with treatment failure and relapse (Kong 
et al. 2006; Sun et al. 2006).  The Beijing clade grows faster in mice, has an 
increased propensity to cause disease, evades the protective effect of the BCG 
vaccination (Spuy et al. 2009), and acquires drug resistance more frequently due to 
SNPs in the mismatch repair genes (Ebrahimi Rad et al. 2003). 
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1.2 Epigenetics  
 
Epigenetics is defined as the reversible changes that occur in the biochemical 
composition of DNA and its associated proteins. Although these changes do not 
modify the nucleotide sequence, they can be propagated through cell division and 
therefore may be heritable and could be associated with almost any known 
phenotype (Bird 2007). Epigenetic modifications play a functional role that 
connects an organism's genome to its environment. Therefore, the control of the 
mechanisms that regulate epigenetic changes may directly be linked to other 
physiological processes such as disease progression in a given environment. 
Conventional genetic modifications alter the coding DNA sequence within an 
organism whose expression leads into a structural change in the encoded protein 
sequence, and subsequently a change in the phenotype. In comparison, epigenetics 
involve alternative forms of direct DNA or protein sequence modifications, such as 
the attachments of methyl groups and other chemical signals. These changes, just 
like in conventional genetic modifications, are heritable and therefore can be passed 
from one generation to the next (Bock & Lengauer 2008). 
 
One of the most commonly and extensively studied form of epigenetics is DNA 
methylation. This is a biochemical process that is mediated by the enzyme DNA 
methyltransferase, and involves the post-replicative transfer of a methyl group from 
S-adenosyl- methionine to the cytosine or adenine DNA nucleotides (Weber & 
Schübeler 2007). The resulting modified bases are the C5-methylcytosine, N6-
methyl-adenine and N4-methylcytosine (Collier, 2009). In both prokaryotes and 
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eukaryotes, previous studies have demonstrated that DNA methylation could be 
playing a direct role in various physiological processes, such as the control of gene 
regulation, embryo development, as well as genomic imprinting and stability. 
Furthermore, DNA methylation constitutes chromatin structure, therefore enabling 
cell growth and differentiation (Bird 2007). 
 
According to (Gardiner-Garden & Frommer 1987), two to seven percent of 
mammalian cytosine residues occur as 5-methylcytosine and are usually observed 
in regions referred to as the CpG islands and mostly are found near the transcription 
start sites. The observation that DNA methylation is involved in the control of gene 
expression is based on the fact that chromosomal regions that undergo through 
active transcription are usually hypo or non-methylated when compared to dormant 
regions (Bird 1992; Razin 1998). 
 
1.2.1 DNA Methylation in Bacteria 
1.2.1.1 An overview of DNA methylation 
 
As recently reviewed by (Davis et al. 2013), DNA methylation is the most common 
form of epigenetic modification in prokaryotic organisms, and is driven by three 
families of methyltransferases (MTases) through a sequence-specific covalent 
attachment of methyl groups to either cytosine or adenine nucleotides. Two of these 
families interact with the exocyclic amino groups to form 6-methyladenine (6mA) 
and 4-methylcytosine (4MC) (Timinskas et al. 1995). The last family of MTases 
catalyzes the formation of 5-methylcytosine (5mC) by methylating the 5- carbon 
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pyrimidine ring of cytosine, and have close homologues in eukaryotes (Kumar et al. 
1994).  
!
Figure 1.1 Graphical representation of methylated  DNA bases. 6-methyl 
adenine (left); 5-methyl cytosine; 4-methylcytosine. The methyl group is 
highlighted in red. (Davis et al. 2013). 
 
 
Bacteria exhibit flexibility in the number of MTases and their corresponding target 
sequence motifs, an observation that is common even in phylogenetically related 
species. However genomic studies have shown that a certain level of DNA 
methylation is conserved in prokaryotes, given that putative DNA MTases 
homologs have been found in at least 94% of over 5805 bacterial genomes 
sequences as of 2014 (Roberts et al. 2010). However, characterisation of these 
sequences hasn’t been performed to establish the extent of this phenomenon. 
Similarly, there’s lack of proper characterisation in other forms of DNA 
modifications such as phosphorothioation (Wang et al. 2011).  
 
 
 
 
 
! 9!
The two enzymes which play a critical role in prokaryotic methylation are the DNA 
adenine methyltransferase (Dam) and the cell cycle-regulated methyltransferase 
(CcrM), which are derived from the Gammaproteobacteria and the 
Alphaproteobacteria respectively. These two enzymes may have evolved from a 
common ancestral gene that lost its restriction domain and therefore adapted its 
function to epigenetic sequence modification (Marinus & Casadesus 2009). 
According to (Casadesús & Low 2006), the 6-methyladenine modification plays a 
role in prokaryotic gene expression by altering changes in DNA-protein 
interactions. 
 
1.2.1.2 DNA methylation recognition sites and DNA Methyltransferases 
 
In prokaryotes, MTases either constitute part of the host restriction-modification 
(RM) system or are independent of RM systems, for example Dam (Casadesús & 
Low 2006). RM systems occur in four main groups namely Types I, II, III and IV, 
with the first three classes being the most common. The Type I RM system are 
structurally composed of two R, two M and one S multisubunit proteins that 
function as a single complex. While the R subunit is primarily involved with the 
cleavage, the M subunit is what drives forward methylation. The S subunit 
determines the specificity for the recognition of the DNA sequence to be 
methylated. All studies have shown that the resultant methylation form is the m6A. 
Cleavage in Type 1 RM systems occurs at variable loci at far proximity from their 
recognition sites. In comparison,  the Type II RM systems are able to identify 
specific recognition sites and the cleavage is performed always at constant loci 
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which are at close proximity to the recognition site, to yield the 5′‐phosphates and 
3′‐hydroxyls. These systems may exist as monomers, dimers and occasionally as 
tetramers, utilizing the Mg2+ ions as the cofactor. Type III systems are made up of 
two protein coding genes, mod and res. Using Adenosine triphosphate (ATP) as an 
energy source, these two subunits are involved in DNA recognition, modification 
and restriction. On identification of the recognition site, cleavage occurs at a 
specific distance away from this locus. The final class is the Type IV RM systems, 
which have not been well characterised. They are made up of only one or two genes 
that cleave only modified DNA. Examples of such modified DNA include 
methylated, hydroxymethylated and glucosyl‐hydroxymethylated bases (Roberts 
2003). 
 
In the case of independent RM systems, the Dam methylase and the CcrM in both 
Gamma- and Alpha-proteomic bacteria respectively mediate adenine methylation in 
prokaryotes. It involves the transfer of a methyl group to the adenosine moieties 
using S-adenosylmethionine as the donor. The DNA targets for this activity are the 
GATC and GANTC sequence motifs, for the Dam and CcrM respectively 
(Casadesús & Low 2006). 
 
1.2.1.3 The role of DNA methylation in bacteria 
 
Most DNA methylation studies have been performed on the model organism, 
Escherichia coli, whose DNA adenine methyltransferase (Dam) has been well 
studied (Barras & Marinus 1989; Marinus & Casadesus 2009; Casadesús & Low 
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2006). The specific mechanisms of methylation in Mycobacterium tuberculosis has 
not been fully established. According to (Jeltsch 2002), the molecular process of 
DNA methylation in bacteria primarily serves three functions which include 1) the 
ability to distinguish own and foreign derived DNA sequences, 2) assisting in DNA 
mismatch repair following replication and 3) guiding the replication machinery 
during the cell cycle. The ability to identify foreign DNA is performed through the 
RM systems and is at the core of defense and immunity in bacteria. The foreign 
DNA, which poses a threat, is identified by its methylation pattern subsequently 
cleaved off to eliminate the threat (Jeltsch 2002). In addition, previous studies have 
demonstrated that DNA adenine methyltransferases are involved in bacterial 
pathogenicity through the control of expression of virulence genes as well as 
the  secretion of known virulence determinants  (Low et al. 2001; Heithoff 1999). 
The mismatch repair system governs DNA replication fidelity. In principle, 
methylation does not occur on the newly synthesized strand, but rather mutations 
are checked on this strand and if found they are corrected on the nonmethylated 
template strand  (Cooper et al. 1993). 
 
Hemimethylation occurs when only one strand of a double-stranded DNA is 
methylated. In Dam methylation sites, this is informative as a direct indication of a 
completely replicated DNA molecule, and also as a label that marks the parental 
template. Given that certain bacterial gene promoters are activated only during the 
hemimethylation state, Dam methylation can be hypothesised to play a role in 
coupling DNA replication with the cell cycle (Barras & Marinus 1989). Due to the 
binding of the seqA protein, and therefore prevention of methylation, the origin of 
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DNA replication remains hemimethylated for the longest period. This provides a 
mechanism to control replication due to the inactive nature of the hemimethylated 
origins of replication (Jelsch 2002). 
 
The role of DNA methylation in bacterial adaptation to a new environment has not 
been fully described. However, the adoption of different phenotypes through phase 
variation has been hypothesised as an outcome of gene expression that is controlled 
by RM associated MTases (Srikhanta et al. 2005; Srikhanta et al. 2011) . 
 
1.2.1.4 Methylation and virulence in pathogenic bacteria 
 
The association of DNA methylation with virulence control was initially established 
and described in Salmonella enterica serovar Typhimurium where the deletion of 
Dam methylase led to a decrease in the ability of the pathogen to colonize mice 
(Heithoff 1999). Since then, there has been extensive evidence that link adenine 
methylation to bacterial virulence. Studies based on model animals have shown 
virulence attenuation during the absence of Dam methylation in Salmonella, 
Haemophilus, and in some strains of Yersinia pseudotuberculosis (García-Del 
Portillo et al. 1999; Watson et al. 2004; Taylor et al. 2005). However, the 
association of virulence with Dam mutants is not a universal phenomenon as has 
been demonstrated in Shigella flexneri (Honma et al. 2004). Interestingly, other 
pathogens have shown the attenuation of virulence when there is an excess of Dam 
methylase (Julio et al. 2001). In Haemophilus influenzae, deletion of Dam leads to a 
decreased ability to invade host cells, as has been observed in S. enterica (Watson 
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et al. 2004). Furthermore, DNA methylation has been shown to influence the 
interaction of a bacterium with its host through regulation and modulation of the 
expression of surface proteins that are linked to virulence (Heusipp et al. 2007) 
 
While bacterial virulence and methylation has been well characterised in major 
pathogens of medical importance, the same is lacking for Dam/Dcm methylation in 
Mycobacterium tuberculosis. A study by (Srivastava et al. 1981) has documented 
that there is no cytosine methylation in the avirulent Mycobacterium tuberculosis 
strain H37Ra, whereas methylation has been confirmed in the virulent H37Rv 
strain. In addition,⁠ (Hemavathy & Nagaraja 1995) have shown that DNA 
methylation is suspected to play a critical role in virulence since the level of 
methylcytosines in the virulent H37Rv was found to be higher than in the avirulent 
strain H37Ra.  
To date there has not been a rigorous study describing DNA methylation in M. 
tuberculosis and virulence using DNA sequencing technologies.  
 
1.3 DNA Sequencing Technology 
1.3.1 First and second generation DNA sequencing technologies 
 
DNA sequencing is a molecular technique that is used to determine the order of 
nucleotides in a DNA molecule (Sanger et al. 1977). Over the course of its 
evolution, the technology has gone through three phases namely; first, second and 
the third generation. The first sequencing method, designated as the first generation, 
was developed by Frederick Sanger (1977) and was based on chain termination. 
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The method uses a single-stranded DNA template, a DNA primer, a DNA 
polymerase enzyme, normal deoxynucleosidetriphosphates (dNTPs), and modified 
di-deoxynucleosidetriphosphates (ddNTPs). The incorporation of ddNTPs by DNA 
polymerase terminates sequence elongation, based on the primer template, since 
they lack a 3’-OH group which is required for the formation of a phosphodiester 
bond between two nucleotides (Sanger et al. 1977) and the ddNTPs are usually 
radioactively or fluorescently labeled for rapid detection in automated sequencers.  
Based on its high accuracy and safety, Sanger sequencing was immediately adopted 
and commercialized, and still remains the gold standard for confirmatory M. 
tuberculosis (Merker et al. 2013; Kato-Maeda et al. 2013) and other mycobacteria 
sequencing (Wynne et al. 2010). 
 
Unlike the first generation sequencing approach, next-generation sequencing (NGS) 
technology is characterised by the high-throughput that is achieved when massively 
parallel chemical reactions simultaneously amplify millions of DNA sequences. 
The key advantages of next-generation sequencing technology are the high 
throughput, which results in millions of short DNA fragments that range from 50 to 
700 base pairs, and the subsequent reduction in sequencing cost (Niedringhaus et al. 
2011). However, this compromises the quality of the obtained short-reads, when 
compared to Sanger sequencing (Niedringhaus et al. 2011). Currently, the main 
commercial vendors of NGS technology include Roche/454, Illumina and Life 
Technologies (Glenn 2011), and they all have the capacity to  generate data of the 
order of giga basepairs (Gbp) per machine per day. 
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The 454 sequencing technology was implemented in 2006 by the 454 Life Sciences 
Corporation and subsequently applied in sequencing the Neanderthal genome 
(Noonan et al. 2006).  The technology is based on the principle of pyrosequencing 
and has the capacity to generate up to 600 megabases per 10-hour run. In 
pyrosequencing, DNA fragments are nebulized and ligated to adapters, after which 
they are fixed onto beads and placed into a  29 micrometer well on a fibre optic chip 
referred to as a PicoTiterPlate. In this well, a mixture of enzymes such as luciferase, 
ATP sulfurylase and DNA polymerase are also added. The incorporation of a 
nucleotide by the DNA polymerase results in the release of a pyrophosphate 
molecule which in turn fuels a downstream set of chemical reactions and the 
production of light when luciferase cleaves oxyluciferin (Mardis 2008a).  
 
Compared to the pyrosequencing technique used by 454, Illumina/Solexa Genome 
Analyzer uses a sequencing-by-synthesis approach (Metzker 2010), where all four 
fluorescently labelled nucleotides are added simultaneously into oligo-primed 
cluster fragments in flow-cell channels along with DNA polymerase. Fluorescent 
labelling is carried out with different colours for each of the four different bases.  
During each cycle in the sequencing protocol, the fluorescent colour which is 
specific to one of the four bases is automatically detected and read, allowing for 
sequence identification and the initialization of the next cycle until the entire DNA 
molecule is fully sequenced (Metzker 2010).  Illumina sequencing offers several 
advantages. For instance, it is possible to sequence multiple strands in parallel due 
to the automated nature and hence massively boost the throughput. Furthermore, 
this technique employs only DNA polymerase as opposed to several, expensive 
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enzymes required by other sequencing techniques such as the 454 pyrosequencing 
(Metzker 2010). At present, the new Illumina HiSeq 2000 Genome Analyzer is 
capable of producing single reads of 2 × 100 basepairs (pair-end reads), and 
generates about 200 giga basepair (Gbp) of short sequences per run. The sequencing 
landscape is currently dominated by the Illumina sequencing technology due to it’s 
adaptability, superior read quality, relatively low cost and the ease of use (Zhang et 
al. 2011).  
  
The principle behind the ABI-SOLiD sequencing technology differs from both 454 
and Illumina in that oligonucleotides that are complementary to a series of bases in 
the template are ligated to a DNA molecule and the identity of the first two bases of 
the ligated oligonucleotide is specified by a flexible four color code with each color 
denoting four different dinucleotides. Given that each base in the template is 
interrogated twice in independent primer cycles, this technique offers some 
significant advantages in terms of accuracy. Furthermore, color reads can be 
converted into base reads if the first base of the sequence is known (Mardis, 2008a; 
Lui et al. 2012). Therefore, in resequencing applications, consideration of SOLiD 
sequencing data can facilitate differentiation between sequencing errors and 
biological artifacts such as SNPs. The drawback to this is that sequence errors result 
in major changes in downstream bases (Horner et al. 2010). 
  
The Ion Torrent sequencing technique is based on the detection of the hydrogen ion 
that is released when a nucleotide is incorporated into a DNA sequence by the DNA 
polymerase (Niedringhaus et al. 2011). The release of hydrogen ions causes a 
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change in the pH within the microwell, which is subsequently detected using an 
ion-sensitive field-effect transistor. The Ion Torrent sequencing machine is the first 
commercial sequencing technology that does not use fluorescence and camera 
scanning. This results not only in smaller equipment, but also in an increase in 
sequencing speed, and low cost (Zhang et al 2011). 
 
1.3.2 Third generation sequencing technology 
 
The single-molecule real-time (SMRT) technology was developed by Pacific 
Bioscience (Menlo Park, CA, USA), and is the first 3rd generation sequencing 
approach to directly observe a single molecule of DNA polymerase while it 
synthesizes a strand of DNA in real time (Eid et al. 2009). This technology directly 
leverages on the speed and processivity of the DNA Polymerase to address many of 
the shortcomings of second generation sequencing (Schadt et al. 2010). The 
technology is based on a SMRT cell, which consists of millions of zero-mode 
waveguides (ZMWs), embedded with one molecule of DNA polymerase and one 
molecule of DNA template which is recorded during the process. During the 
reaction, the DNA polymerase adds a nucleotide into the complementary strand and 
cleaves off the fluorescent dye previously attached to that nucleotide (Figure 1.1). 
Inside the machine, there is a camera that captures fluorescent signal in real time 
and records it in a movie format. This facilitates the derivation of the interpulse 
duration (IPD) from the signal differences, a feature that is paramount in predicting 
structural variance in the sequence, and is widely applied in epigenetic studies such 
as the identification of DNA methylation. The rate at which the DNA polymerase 
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molecule incorporates each nucleotide into the growing strand varies depending on 
the type of modifications present on each base (Clark et al. 2012). 
  
 
!
Figure 1.2. Detection of DNA modifications using PacBio SMRT sequencing. a 
represents the sequencing reaction with the thymine nucleotide incorporated into 
the growing strand corresponding to a methylated (top) and unmethylated adenine 
(bottom). b represents the SMRT fluorescence real time detection. The x-axis 
shows the time for the nucleotide incorporation and the y-axis represents the 
fluorescence intensity. The interpulse duration (IPD) represented by the dashed line 
shows a delayed incorporation of the thymine due to the methylated adenine (top) 
compared to a shorter time for an unmethylated adenine (bottom) (Flusberg et al. 
2010). 
 
PacBio SMRT sequencing offers four major advantages when compared to second 
generation sequencing; 1) rapid sample preparation which can be achieved in four 
to six hours instead of days, 2) elimination of errors and the bias that is associated 
with Polymerase Chain Reaction (PCR) amplification, 3) high turnover rate as the 
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runs can be completed within a day and 4) long average read length of up to 4000-
6000%base pairs (bp), which is longer than any derived from the second-generation 
sequencers. Although the throughput of the PacBioRS is lower in comparison to the 
second-generation sequencers, the technology is widely applied in clinical 
laboratories, more so in microbiology research (Liu et al. 2012). 
  
Second generation sequencing technology does not sequence long repeat regions 
effectively due to the size of the short reads (50 -250 base pairs). In M. tuberculosis 
insertion elements and highly repetitive regions such as the PE–PPE genes (Cole et 
al. 1998) are often not adequately sequenced due to the short reads resulting in gaps 
in coverage and lower confidence when mapped to the reference genome. The long 
reads from PacBio mitigates these issues and provides an advantage over 2nd 
generation sequencing methods (Galagan 2014). 
 
1.3.3 Application of DNA sequencing to bacterial genomics 
 
Due to their small genomes, bacteria are easy and relatively cheap to sequence. 
Therefore, various studies that employ next-generation sequencing technology have 
been carried out ranging from outbreak patterns (Roetzer et al. 2013), drug 
resistance (Farhat et al. 2013), strain variation (Roetzer et al. 2013) and human 
microbiome metagenomics (Qin et al. 2010). Given that pathogens evolve 
continually driven by the acquisition of novel mutations, the sequencing of clinical 
isolates is of great importance especially if it can be analysed in the light of 
virulence markers, such as those conferring antibiotic susceptibility and resistance 
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(Mardis 2008b). For example, Nowrousian (2010) proposes that such information 
can be used to infer microbial evolution, identifying differentiating markers 
between pathogenic and nonpathogenic strains. 
  
As of 2014, there are 23 complete and 43 draft M. tuberculosis genomes in the 
RefSeq database (Pruitt et al. 2007) at the National Center for Biotechnology 
Information (NCBI). Due to the success of M. tuberculosis and its ability to evade 
the immune system and also confer resistance to TB drug treatments, which 
presents an ongoing challenge, it is imperative to get a better understanding of this 
pathogen and identify its ability to persist with infection. In addition to studying 
emerging drug resistance patterns, the development of new drugs and discovery of 
biomarkers, prompts the need for analysing M. tuberculosis genomes (Mathema et 
al. 2006; Comas & Gagneux 2009) 
 
The H37Rv laboratory reference strain was the first M. tuberculosis genome to be 
sequenced and annotated in 1998 by Cole and colleagues. To date, it is the most 
accurately annotated and well described strain of M. tuberculosis and is extensively 
used in various genomic studies as the reference strain of choice. The genome 
comprises of 4,411,532 base pairs, and approximately 4000 protein coding genes, 
and has a high GC content of around 65%. The H37Rv genomic and annotation 
information is stored in a public database TubercuList (http://tuberculist.epfl.ch/) 
(Lew et al. 2011). The sequencing of the whole genomic DNA of M. tuberculosis  
strain H37Rv in 1998 (Cole 1998) using Sanger sequencing was a turning point in 
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tuberculosis research, paving the way for the study of biology, metabolism and 
evolution of this pathogen (Metzker 2010).  
 
In May 2011, during an ongoing outbreak of an exceptionally virulent shiga-toxin 
producing Escherichia coli O104:H4 in Germany, PacBio sequencing technology 
was employed not only in the genome assembly, but also to provide insight into the 
organism's methylation profile. More than 3000 people were infected with the new 
strain which was a hybrid of the entero-aggregative and the entero-hemorrhagic E. 
coli. The study revealed that the new strain had been infected with a bacteriophage 
leading to the acquisition of a shiga-toxin encoding gene and a new restriction 
modification (RM) system, which subsequently affected the transcription of several 
genes some of which are associated with virulence (Fang et al. 2012). 
 
1.3.4 Whole genome bisulphite sequencing 
 
Bisulphite genomic sequencing is the gold standard in methylation analysis. This 
method is used to identify methylated cytosines and has mostly been used to study 
cytosine, and specifically the CpG methylation patterns in eukaroytes. (Lister et al. 
2008; Lister et al. 2009; Meissner et al. 2008). In E. coli, using whole genome 
bisulphite sequencing, methyl cytosines have been studied during different cell 
cycle stages and found to be regulators of stationary phase gene expression 
(Kahramanoglou et al. 2012). Currently, next-generation sequencing, coupled with 
sodium bisulphite modification of DNA, has proven to be a powerful method in the 
analysis of DNA methylation at single nucleotide resolution (Chatterjee et al. 2012)⁠. 
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In whole genome bisulphite sequencing, genomic DNA is treated with sodium 
bisulphite which converts unmethylated cytosines to uracil. The uracils are read as 
thymines by DNA polymerase, so amplifying bisulphite-treated DNA by PCR 
yields products where unmethylated cytosines appear as thymines. After subjecting 
the bisulphite-treated genomic DNA to next generation sequencing, the methylation 
state is determined from the sequence alignments by comparing the modified DNA 
with its original sequence (Krueger et al. 2012). 
  
Bisulphite sequencing has some disadvantages in that 1) the treatment and sample 
preparation steps are time-consuming and costly, 2) DNA degradation can occur 
due to the bisulphite chemical treatment, 3) the complexity of the genome is 
reduced due to the conversion of all cytosines to thymines, which affects the 
mapping to the reference genomes, 4) methylcytosine and hydroxymethylcytosine 
cannot be discriminated and 5) this method is only restricted to identifying one type 
of nucleotide (cytosine) methylation (Flusberg et al. 2010). PacBio SMRT 
sequencing expedites this in that it directly sequences and identifies methylated 
bases without the need for prior bisulphite treatment, thereby providing a direct 
measurement. 
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1.4 Bioinformatics and NGS analysis 
1.4.1 Data generation and format 
 
Since its first description by Frederick Sanger in 1971, DNA sequencing (Sanger et 
al. 1977) has gone through three technological phases, also termed as generations, 
with each phase improving upon the previous one. This has led to huge amounts of 
data being generated for analysis and biological interpretation (Mardis 2008b). 
Recently, technical advancement in DNA sequencing has outpaced Moore’s Law, a 
prevailing phenomenon that describes the trend observed in the development of 
computer hardware, whereby every two years the number of transistors that can be 
fitted on a single Integrated Circuit (IC) doubles (Dewitt et al. 2012). This calls for 
development of computational tools, algorithms and databases for analysing and 
managing the massive data which is currently posing a challenge for bioinformatics 
and computational biology (Zhang et al. 2011).  Some of the areas of interest 
include 1) sequence alignment and mapping, 2) genome assembly 3) data storage 
and retrieval (Ansorge 2009). The main disadvantages arising from the second 
generation sequencing platforms is the short read-length and decreased sequencing 
accuracy, compared to conventional Sanger sequencing. These pose significant 
algorithmic challenges for downstream analysis (Shendure & Ji 2008).  
 
The base sequence in both first and second generation sequencing is as a result of 
decoded light signals through a process referred to as base-calling. Although this is 
dependent on the specific technology in use, each called base is associated with a 
probability score of accuracy referred to as the quality score. One of the widely 
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used quality scoring system is the phred score (Q), which is expressed 
mathematically as Q =  -10 log10 P, where P is the base-calling error probability 
(Ewing et al. 1998; Ewing & Green 1998). Therefore, a quality score of 20 
corresponds to an error probability of 1 in 100. Different file formats have been 
adopted in the representation of both sequences and their corresponding quality 
scores, with the FASTQ being the most widely applied format by the next 
generation sequencing platforms. The first challenge encountered in the analysis of 
sequencing data is the file conversion as most software are designed to take data 
that is in a specific format (Nowrousian 2010). 
 
Data obtained from the Pacific Biosciences (PacBio) sequencing technology (Eid et 
al. 2009), which is currently the representative platform for the third generation 
sequencing technology, differs significantly from the FASTQ formats of the first 
and the second (NGS) technologies in that 1) PacBio raw data in movie format and 
2) sequencing information is stored in Hierarchical Data Format (HDF5) files, 
which contain information about the base calls, quality scores and meta data such as 
the polymerase kinetics. 
 
1.4.2 Data analysis and algorithms 
 
Other than the de novo assembly of sequenced genomes and genome fragments, 
genome mapping is a huge and often challenging area in the computational analysis 
of sequencing data. The overall objective is to align the sequenced reads to a known 
reference genome and determine all the regions of similarity and differences 
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between the two datasets (Ruffalo et al. 2011). One of the challenges in mapping is 
in the determination of the mismatches that can be allowed for any given read to be 
considered as aligned to a specific region on the reference genome, since 
mismatches may arise not only being biological artifacts, but rather as sequencing 
errors. The presence of repeats in the sequenced reads also poses a huge challenge 
in data analysis as they erode specificity and a single read can be mapped on to 
different regions of the reference (Nowrousian 2010). The principle underlying 
mapping software is the computational unique k-mers and their indices in either the 
reference genome or the reads. Several criteria have been used as a guide during the 
design of the mapping algorithm, for example the read quality scores (Nowrousian 
2010). 
 
Many of the mapping software are specially designed for the mapping of short reads 
generated by second generation sequencing technologies but not for long reads. 
Specialized mapping algorithms have been designed to deal with the long reads and 
movie format derived from the PacBio sequencing technology. The Basic Local 
Alignment with Successive Refinement (BLASR) algorithm is primarily used in the 
mapping of PacBio reads. The program searches for at least 10 kmers of size 15 
using a Burrows-Wheeler transform algorithm and then uses them to anchor the 
read onto the reference sequence. Once the reads have been anchored, a dynamic 
alignment algorithm is employed to align the entire read (Chaisson & Tesler 2012). 
In addition to BLASR, PacBio has implemented a general-purpose data analysis 
platform, called SMRT Pipe, which performs a wide array of functions such as 
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logging and data management, parallel computation, error management, parameter 
optimization, and storage of temporary files.  
 
 
1.5 Rationale 
 
Molecular analysis of numerous M. tuberculosis clinical isolates has revealed that 
the species exhibits a high level of similarity at the genetic level with all strains 
showing greater than 99% genetic similarity (Hershberg et al. 2008). However, this 
level of genetic similarity does not necessarily translate to phenotypic homogeneity. 
Based on the numerous inter- and even intra-strain differences, previous studies 
have shown that some  M. tuberculosis clones may undergo a virulence enhancing 
genetic alteration that potentially lead to occurrences of tuberculosis outbreaks 
(Hanekom et al. 2007; Nicol & Wilkinson 2008). In addition, van der Spuy et al 
(2009) has suggested that the Beijing strain family may possess an increased 
virulence capacity over other strains. Furthermore the Beijing genotype  is the 
dominant  strain in the Western cape, South Africa (Hanekom et al. 2007). In a 
study by de Souza et al. (2010) involving two strains that are closely related 
members of the Beijing strain sublineage 7 family, a virulence characterisation 
analysis highlighted significant differences between the two. While one strain was 
responsible for only a single case of disease, the other one was responsible for 147 
cases. The strains have been designated the terms ‘hypo-virulent’ and ‘hyper-
virulent’ respectively, and their virulence characteristics have been confirmed in a 
mouse model by (Souza et al. 2010). 
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DNA methylation is a largely untapped area of research in M. tuberculosis and has 
been  poorly described in the literature  especially  given its connection to virulence. 
However,  it has  been extensively studied along with its role in virulence in other 
pathogenic bacteria such as E.coli.  To date only three studies (Srivastava et al., 
1981; Hemavathy and Nagaraja, 1995; Shell et al., 2013) have identified DNA 
methylation (either m6A and/or 5mC) in M. tuberculosis H37Rv, but none have 
elucidated genome-wide methylome characterisation for the Beijing strains which 
possess an enhanced virulence capacity over other M. tuberculosis strains.   
 
Previous attempts to identify 5mC using  bisulphite Illumina sequencing in both of 
these strains did not reveal any 5mC. Since 5mC was not detected in these strains, 
this led to the question if DNA methylation occurred on another nucleotide other 
than cytosine. With the recent availability of PacBio sequencing technology with 
applications in bacterial methylome analyses, the DNA methylation profiles of  the 
M. tuberculosis hyper and hypo-virulent  strains were investigated. The aims are as 
follows: 
 
1. To characterise a global DNA methylation profile for  hyper-virulent and hypo-
virulent Mycobacterium tuberculosis  Beijing strains from single molecule real time 
sequencing data by: 
 
1.1 Identification and characterisation of DNA methylated bases viz. N4 
methylcytosine and  N6 methyladenine. 
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1.2 Identification of methylated sequence motifs  and their subsequent 
methyltransferase enzymes and RM systems. 
 
1.3 To compare the unique and shared methylated genomic loci of the hyper-
and hypo-virulent strains with the aim of understanding the different 
disease phenotypes caused by these strains. 
 
  
2. To computationally analyse adenine methylation in promoter regions. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Single Molecule Real Time DNA Sequencing 
 
Two strains of Mycobacterium tuberculosis Beijing genotype sublineage 7; 1) 
hyper-virulent and 2) hypo-virulent strain, were sequenced using the Pacific 
Bioscience (PacBio) Single Molecule Real Time (SMRT) sequencing technology 
(Flusberg et al. 2010), in order to identify DNA methylation and other base 
modifications. The SMRT sequencing technology is ideal since it enables not only 
the sequencing of DNA, but also the detection of various other DNA base 
modifications. 
 
The DNA samples were prepared as per the standard SMRTBell template protocol 
(Travers et al. 2010) generating a 1 kb insert size library. The samples were 
subjected to the C2 chemistry on the PacBio RS sequencing machine. This 
experiment was carried out at GATC Biotech in Germany. A total of 5 SMRT cells 
was used, yielding a sequencing coverage of 50x, 25x per strand of DNA with 2 
sets of 45 minute movie protocol. The PacBio raw reads were downloaded from the 
GATC Biotech web portal and bioinformatics analysis was performed as outlined in 
the next section. 
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Figure 2.1 Overview of data analysis. A) Represents the overview of the 
methodology for the identification of methylated DNA bases from the PacBio reads. 
B) Following identification of methylation sites, characterisation of the genic 
positions of methylated loci in uniquely and shared methylated positions between the 
hyper and hypo-virulent strains. C) Represents the promoter region methylation 
analysis and subsequent enrichment of unique and shared methylated promoter 
associated genes.
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2.2 Computational Analysis of the PacBio sequencing data 
 
The SMRT analysis platform, version 1.3.3, was downloaded from the PacBio web 
portal (https://github.com/PacificBiosciences/SMRT-Analysis/). Data analysis was 
performed using The RS Modification and Motif Analysis protocol, with the default 
parameters using the graphical user interface. The SMRT analysis software is 
memory intensive and functions as a standalone tool thereby utilising all the 
memory and hard drive capacity on the server. The minimum disk space 
requirement is  250 GB per node. 
The protocol analyses the interpulse distances to find bases with incorporation 
kinetics that differ statistically significantly from those of unmodified bases.  This 
protocol comprises of the following steps described below: Quality filtering of 
reads; Mapping; Base Modification detection  and Motif finding.  
 
2.2.1 Quality filtering of  Raw Reads 
 
Quality filtering of PacBio Raw reads which focuses on; 1) adapter removal, 2) 
read-length settings, 3) subread length settings and 4) read quality scores. In this 
analysis, all the adapters were cleaved, while both the minimum read length and the 
subread length were set at 50.  In the read quality assessment, the minimum cutoff 
score was set at 0.75. 
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2.2.2 Mapping to the H37Rv reference genome 
 
Read mapping was performed using the Basic Local Alignment with Successive 
Refinement (BLASR) (Chaisson & Tesler 2012) software which is incorporated 
into the SMRT Analsysis software portal. The BLASR algorithm is specially 
designed to cater for the long reads that are generated by the PacBio sequencing 
protocol. Prior to mapping the software filters out low quality reads which are 
usually characterised by relatively shorter lengths of less than or equal to 50 
nucleotides, and are as a result of premature read termination during the 
sequencing. 
 
The latest assembly of the Mycobacterium tuberculosis H37Rv genome (Cole et al. 
1998), was downloaded from the RefSeq database (Pruitt et al. 2012) at the 
National Center for Biotechnology Information (NCBI) and used as the reference 
genome in read mapping. This procedure evaluates the maximum number of 
matches of each read to the reference sequence. The maximum divergence, which 
defines the allowed flexibility of the read in mapping to the reference, was set at 
30%. The minimum anchor size was set at 12, implying that at least 12 base pairs in 
the read must match to the reference. 
 
2.2.3 Base Modification calling 
 
This step involves the identification of modified bases, as well as sequence motifs. 
In order to detect any base modification, the Mapping QV score, which represents 
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the confidence with which a read maps uniquely to the selected genomic interval, 
was set at 10 as the cutoff. Reads that fall within repeated genomic segments are 
automatically assigned low Mapping QV scores, and therefore subsequently 
removed from the analysis, so as to avoid erroneous base modification call as a 
result of mismapped reads. 
 
The base modification and identification step uses an in silico kinetic reference and 
a t-test–based kinetic score to detect modified base positions within a genome. In 
this analysis, the log-transformed p value from the t test −10 log (p-value), which is 
used as the kinetic score, was set at the threshold value of 100. Therefore, each 
reference base position that met this threshold was identified as methylated. In the 
identification of motifs, a minimum score of 40 was considered for assigning motifs 
to any given modified base. Based on the Inter-pulse Duration (IPD) ratio, and the 
specific kinetic signatures, different types of DNA base modifications were 
determined. These include; 1) 4-methylcytosine (4-mC), 2) 6-methyladenine (6-
mA) and 3) modified base. 
 
Once the methylation sites were predicted, further bioinformatics downstream 
analysis was carried out in order to characterise the methylome for the two strains 
and to determine their methylation patterns. 
 
SMRTView® software from Pacific Biosciences was used to view the analysis and 
methylation sites and mapping results. 
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2.3 Genome-wide methylome characterisation  
 
The methylation coordinates  were separated by their strand orientation occurrence 
and analysed as described hereunder. The number of unique and shared m6A and 
m4C methylation sites between the hyper and hypo-virulent strains was 
determined.  The methylation sites were also analysed for the genomic features they 
specifically overlap with. 
 
 
2.3.1 Identification and characterisation of methylated recognition motifs and 
methyltransferases 
 
Only confident methyl sites with a modification QV (confidence score) of 40 were 
selected and their sequence motifs further analysed. Subsequently, the predicted 
motifs sequences were searched for in the published Restriction Enzyme 
Database  http://tools.neb.com/~vincze/genomes  (REbase; Roberts et al. 2010), 
using the M. tuberculosis whole genome sequence as the query. REbase contains 
detailed information on prokaryote restriction enzymes, DNA methyltransferases 
and related proteins involved in the biological process of restriction-modification. 
This analysis yielded known methyltransferases and Restriction Modifications 
(RM) systems specific to the Mycobacterium tuberculosis H37Rv. In addition, 
genes encoding the methyltransferase enzymes in M. tuberculosis were searched 
for, in the REbase database.  
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2.3.2 Genic methylation Analysis and characterisation 
 
Once the methylation sites were separated by their strand occurrence, the next step 
was to determine which genomic features they overlap in the H37Rv genome. The 
H37Rv annotation file, which contains all the genomic annotations in General 
Feature Format (GFF), was downloaded from the RefSeq database (Pruitt et al. 
2012). In order to determine the genomic features where methylation sites overlap, 
intersectBed from the Bedtools sequence analysis software  (Quinlan & Hall 2010) 
was used. The input files were the list of methylation genomic positions and the 
H37Rv genome annotation, both of which were in GFF format . 
(intersectBed -wb -a input.txt -b annotation.gff >output.txt) 
 Once a list of genic methylation sites was determined for the hyper and hypo-
virulent strains, a functional enrichment analysis using the Tuberculosis Database 
(TBDB) (Reddy et al. 2009), was performed in order to determine which functional 
categories were over represented. The Clusters of Orthologous Groups (COG) 
categories (Tatusov et al. 2003) were used as the functional references. This was 
run for the uniquely methylated genes in the hypo and hyper-virulent strains, as 
well as the shared methylated genes.  
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2.3.3 Intergenic DNA methylation Analysis 
2.3.3.1 Analysis of methylated promoter regions 
 
The overall aim was to computationally analyse DNA methylation occurring in 
promoter regions of operons. 
 
2.3.3.1.1 Operon prediction and organisation 
 
Genes in an operon are expressed together because they are co-transcribed or under 
the regulation of the promoter of the head gene in the operon (Mcguire et al. 2012). 
Hence it is important to consider operons and promoters of operons. The aim was to 
characterise the intergenic methylation sites, specifically in the promoter region of 
the operon, which may affect gene regulation. 
The Database of PrOkaryote OpeRons (DOOR2) online operon predictor software 
(Mao et al. 2009) http://csbl.bmb.uga.edu/DOOR/annotate.php was used to predict 
the operons for the Mycobacterium tuberculosis H37Rv genome.  
 
The input files uploaded for the M. tuberculosis H37Rv genome were the gene 
location file in NCBI protein table format;  the protein sequences and the genome 
sequence both in fasta format. The output is a tab-delimited file containing the list 
of predicted operons organised by their genomic positions and annotation 
information based on the COG category. 
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2.3.3.1.2  Comparative analysis of methylated promoters between hyper and 
hypo-virulent strains 
 
The DOOR2 analysis, as described in section 2.3.3.1.1 , yields operons which are 
clusters of genes transcribed into a single polycistronic mRNA. The largest 
obtained operon was comprised of 6 genes. Promoter region’s coordinates were 
identified for each operon by subtracting 100 base pairs upstream of the first gene 
in the operon. In order to identify the methylation sites falling within the predicted 
promoter regions, the m6A coordinates were compared to those of the target 
promoter region. If the methylation sites were i) greater than or equal to the 
promoter start coordinate or ii) less than or equal to the promoter end coordinate, 
they were assumed to be associated with the promoter region. Methylation sites that 
fell outside of this region were excluded. This was performed for both the hyper and 
the hypo-virulent M. tuberculosis strains to generate two lists of methylated 
promoter regions. Thereafter, the unique and the shared promoter regions, between 
the hyper and the hypo-virulent strains, were identified through direct comparison 
using the Unix ‘cmp’ command. The genes of these promoters were then further 
interrogated for their functional annotation using the Tuberculist web utility at 
http://tuberculist.epfl.ch/ . 
 
2.3.3.2 Functional enrichment analysis of the methylated promoter operons 
 
Functional enrichment of these genes was carried out using the TBDB gene 
enrichment online tool, to determine which functional categories were 
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overrepresented. The TBDB web server also uses the Gene Ontology (GO) terms 
and Clusters of Orthologous Genes (COG) categories to augment the functional 
enrichment. A corrected p-value of 0.05 was used as the cutoff. 
 
2.3.3.3 Metabolic Pathway Analysis 
 
The uniquely methylated genes for the hyper and hypo-virulent strains, were 
mapped onto the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways 
(Ogata et al. 1999) in order to gain insight into their biological functions and 
relevance. The KEGG Search &Color Pathway tool 
http://www.genome.jp/kegg/tool/map_pathway2.html was used to map the list of 
genes on to the KEGG pathway maps of the M. tuberculosis H37Rv reference 
pathways.  
 
The methylation genomic loci in GFF format were visualized in a local version 
Gbrowse genome browser and SMRT®View.  !
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CHAPTER 3: RESULTS AND DISCUSSION 
 
Overview 
In this study, a comparative approach was employed in the analysis, and 
characterisation of the methylomes of two closely related Mycobacterium 
tuberculosis strains. The two strains, the hyper- and the hypo-virulent, belong to the 
same Beijing sublineage 7, and exhibit vastly different clinical phenotypes. The 
goal was to determine if there were any differences in DNA methylation patterns 
between the two strains that could explain the observed phenotypic differences. To 
date, only one study (Shell et al., 2013) has identified DNA methylation using NGS 
approaches (5mC and m6A) in M. tuberculosis despite its clinical importance as a 
pathogen. Furthermore, there have been no studies focused primarily on Beijing 
genotype strains which are predominant in the Western Cape region of South 
Africa. The data in this research was generated using the most recent single 
molecule sequencing technology available, Pacific Biosciences. A computational 
approach, as described in the methods chapter, was formulated and applied to 
enable the identification of the DNA methylation patterns, as well as their 
functional annotation.  
 
This chapter presents the results, first by the prediction of the DNA methylation 
profiles for each of the two genomes, followed by the subsequent downstream 
analyses and characterisation of the identified methylated loci. Accordingly, this 
study provides a comprehensive genome-wide methylation analysis of the hyper- 
and hypo-virulent M. tuberculosis Beijing genotype strains. 
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3.1 Description of methylation patterns 
3.1.1 Mapping hyper-virulent and hypo-virulent M. tuberculosis Beijing 
genotype strain genomes to the reference M. tuberculosis H37Rv genome 
 
The SMRT sequencing platform generated reads with an average length of 2,461 
base pairs (bp). The reads, which resulted from the adapter sequence trimming, are 
known as the ‘subreads’, which had an average length of 562 and 568 bp for hypo- 
and hyper-virulent strains respectively, were obtained (Table 3.1).  
 
The H37Rv laboratory strain is the most accurately annotated M. tuberculosis 
genome  to date and was appropriately selected since the downstream methylation 
analysis  is dependent on accurate annotation and biological interpretation. 
 
Table 3.1 A summary of the mapping statistics for hyper-virulent and hypo-virulent 
genomes 
 Hyper-virulent Hypo-virulent 
Mean Mapped Subread Accuracy 87.54% 86.9 %  
# of Reads 231363 135729 
# of Mapped Reads 209668 119955 
# of Mapped Subreads 779104 439319 
Mean Mapped Readlength 2488 bp 2461 bp 
Mean Mapped Subread Readlength 568 bp 562 bp 
Mean Depth of coverage of H37Rv 96 53.69  
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The tabulated results (Table 3.1) show that the hypo-virulent genome was 
sequenced at a lower coverage, which resulted in a lower number of reads 
compared to the hyper-virulent strain. However, the same number of SMRT cells 
were used during the sequencing of both genomes. This implies that there was some 
loss in starting DNA material during the library preparation step (C Konig, personal 
communication). 
 
 
3.1.2 Identification and characterisation of methylomes in hyper-virulent and 
hypo-virulent strains 
 
The methylation state of every base for the hyper- and hypo-virulent strains was 
determined with respect to the H37Rv genome in real time by measurement of 
DNA polymerase kinetics during the sequencing reaction. This ensures the 
identification of DNA base modifications at the single base pair resolution. 
 
The real time measurement of kinetics of the DNA polymerase enables the 
detection of modified DNA bases, which could be in the form of damaged DNA 
bases due to oxidative stress or epigenetic changes such as methylated DNA bases. 
The rate at which the polymerase incorporates each nucleotide is slowed down 
when encountering a modified base as opposed to an unmodified base. This 
difference in time between nucleotide incorporations is the interpulse duration 
(IPD)  ratio, thus identifies a base as modified. Methylated bases such as N6 
methyladenine and N4 methylcytosine have distinct kinetic signatures on the 
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polymerase within a 12 bp window  and hence are  detected accordingly to the in 
silico computational reference model (Figure 3.1).  (Clark et al. 2012) 
 
 
 
Figure 3.1 An illustration of the IPD ratio of 6.20 (purple block) for a methylated 
adenine within the predicted motif CACGCAG in the forward strand. The 
methylated adenine also occurs within the OmpA gene.  
 
 
Base modifications, based on the kinetic signature of a specific modification type, 
were identified through comparison to an in silico control reference, for every 
position in the H37Rv genome. The PacBio sequencing detected 3 types of bases 
modifications namely, N6-methyladenine (m6A), N4-methylcytosine (m4C) and 
modified base, which refers to any unidentified bases other than the specific 
modified types mentioned above. These were excluded from the analysis due to 
their non-specific nature. The modification QV (ModQv) is  the statistical phred-
like score that quantifies the extent to which a base is correctly predicted as 
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modified. A score of 20 denotes a 99% chance that the base is modified and also 
corresponds to a p value of 0.01. 
 
The IPD ratio for a methylated position is the average IPD ratio of all the molecules 
at that position which includes non-methylated and methylated strands.  A 
heterogeneous sample containing a mixture of methylated and non-methylated 
strands of DNA hence will appear to have partial methylation at that site and will 
also have a lower modification Qv. (C Konig, personal communication). 
 
The total number of methylated bases and their frequencies identified in hyper-
virulent and hypo-virulent strains are summarized in Table 3.2. 
 
 
Table 3.2 The composition of base modifications identified in hyper-virulent and 
hypo-virulent strains. The percentages are indicated in parentheses. 
 Hyper-virulent Hypo-virulent 
m6A 1946 (2.3%) 1825 (4.6%) 
m4C 3049 (3.7%) 2011 (5.4%) 
Modified base 81119 (94%) 35779 (90%) 
Total 86187 39672 
 
 
As seen in Table 3.3, the m4C has a low methylation signal based on the ModQv. 
The m6A sites that do not occur within predicted motifs, have a lower Modification 
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Qv compared to the sites within motifs. The low modification score could be due to 
the low sequencing coverage or sequencing errors in these regions. 
 
Table 3.3 A summary of the coverage and ModQv of m6A and m4C in hyper-
virulent and hypo-virulent strains. 
  Hyper-virulent Hypo-virulent 
Mean coverage m4C 47 27 
Mean ModQv m4C 31 24 
Mean coverage m6A 47 26 
Mean ModQv m6A 40 29 
Mean ModQv m6A with motif 80 50 
 
 
3.1.2.1 Pinpointing the genomic locations of methylation 
 
Figure 3.2 summarises the frequency of methylation sites occurring in genomic 
features. Out of the total methyladenines identified, 38.2% and 40% of these sites 
occur within genes for hypo-virulent and hyper-virulent  strains respectively. Both 
strains have 44.8% methylcytosines out of a total of all methylcytosines occurring 
in genes (Figure 3.2). The remainder, which is the majority of the methylation, 
occurs in intergenic regions as shown in Figure 3.3.  
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Figure 3.2 Frequency of genic methylation sites in hyper-virulent and hypo-virulent 
strains for both m6A and m4C sites. 
 
 
 
 
Figure 3.3 Frequency of intergenic methylation sites in hyper-virulent and hypo-
virulent strains for both m6A and m4C sites. 
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The majority of the intergenic methyl adenines have 897 shared positions between 
hyper-virulent and hypo-virulent strains, with 272 occurring uniquely in the hyper-
virulent strain and 235 unique sites for the hypo-virulent strain.  
 
A total of 980 and 939 methyl adenines were detected by the software in the 
negative strand for the hyper-virulent and hypo-virulent respectively (Table 3.4). 
There were 965 and 885 methyl adenines detected in the positive strand for hyper-
virulent and hypo-virulent strains respectively. A Fishers statistical test did not 
show any overrepresentation of strandedness for total adenine methylation, in both 
the hyper- and hypo-virulent strains. 
Since this is a comparative analysis between two strains, a unique and shared 
methylation approach between the hyper- and hypo-virulent strains, was used in the 
following reported analyses. As a general trend, the shared methylation sites occur 
mostly within the predicted motifs. Most of the m6A methylation sites are shared 
between the hyper- and hypo-virulent with only a small percentage of the total m6A 
sites being unique to either strain.  
 
Table 3.4 Stranded methylation in hyper-virulent and hypo-virulent strains 
 Hyper-virulent  Hypoviulent  
 Neg strand Pos strand Neg strand Pos strand 
m6A genic 407 (42%) 375 (39%) 360 (38%) 338 (38%) 
m6A intergenic 577 (58%) 593 (61%) 582 (62%) 550 (62%) 
Total 980 965 939 885 
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3.1.3 Summary 
N4-methylcytosine is usually targeted by methyltransferases which belong to 
restriction modification systems. Although less understood than m6A RM systems, 
m4C methylated bases can be detected using the PacBio sequencing technology.  
 
The m4C had low Modification Qv scores, which represents the confidence that a 
base is modified (Table 3.3), despite having a consistent coverage as that of the 
m6A. It can be deduced that the m4C methylation signal is weaker in comparison to 
that of m6A signal in the hyper- and hypo-virulent genomes. Murray et al (2012) 
have seen a similar result with the detection of m4C in Bacillus cereus having less 
than half of the m4C motifs methylated as targeted by their respective 
methyltransferases. Davis et al (2013) suggest that this might be due to a weak 
intensity of the m4C signal. 
 
m4C bases was identified in the both the strains, albeit at a low confidence. This 
had not been previously described in M. tuberculosis. However, we did not proceed 
with further downstream analysis due to the low signal, which could be interpreted 
as false positives (C Konig, personal communication). 
 
The following sections focus on an in-depth m6A characterisation and annotation 
between the hyper-virulent and hypo-virulent strains.  
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3.2 Methylated sequence motifs 
 
DNA methylation in bacteria is carried out by an enzyme known as a 
methyltransferase which confers a methyl group to the nucleotide base.  These 
methyltransferases identify a recognition sequence or motif in which the respective 
base is methylated. Methyltransferases belong to a Restriction Modification (RM) 
system along with its cognate restriction enzyme which functions as the bacteria’s 
defence against foreign viruses among other roles. Hence it is imperative to identify 
these motifs, which provide information on the type of restriction modification 
system involved.   
The 4 predicted motifs for high scoring methylated positions with a Modification 
Qv cutoff of 35 are presented in Tables 3.5 and 3.6. The methylation sites not 
identified within a predicted motif were also included in the downstream analysis.  
 
There was a higher percentage of motifs that were methylated in the hyper-virulent 
genome compared to hypo-virulent genome, (Tables 3.5 and 3.6). Out of 1945 m6A 
sites, 1441 occur in predicted motifs for the hyper-virulent strain, while the other 
505 (26%) are independent of the predicted motifs. On the other hand, 1291 m6A 
sites in the hypo-virulent strain occur in predicted motifs, out of a total of 1824 
m6A sites. The other 535 sites, which translates to 42%, are not associated with any 
of the predicted motifs. Therefore, the observed hypo-virulent methylation signal is 
weaker given the low coverage and the low modification scores, when compared to 
the hyper-virulent strain (Tables 3.5 and 3.6).  
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Table 3.5 Summary of methylated sequence motifs in the hyper-virulent strain. 
Motif Modified 
Position 
% 
Motifs 
Detected 
# of 
Motifs 
Detected 
# of 
Motifs 
in 
Genome 
Mean 
Modification 
QV 
Mean 
Motif 
Coverage 
Partner Motif 
CACGCAG  6 95.24 781 820 82.1 45.3  
GATNNNNRTAC  2 87.05 316 363 84.1 47.4 GTAYNNNNATC 
GTAYNNNNATC  3 84.57 307 363 78.9 47.8 GATNNNNRTAC 
CTGGAGGA  5 24.11 27 112 52.2 56.0  
Methylated base highlighted in bold 
 
Table 3.6 Summary of methylated sequence motifs in the hypo-virulent strain.  
Motif Modified 
Position 
% 
Motifs 
Detected 
# of 
Motifs 
Detected 
# of 
Motifs in 
Genome 
Mean 
Modification 
QV 
Mean 
Motif 
Coverage 
Partner Motif 
CACGCAG  6 64.27 527 820 58.3 29.2  
GTAYNNNNATC  3 58.95 214 363 55.2 28.5 GATNNNNRTAC 
GATNNNNRTAC  2 57.02 207 363 58.1 28.9 GTAYNNNNATC 
Methylated base highlighted in bold 
 
 
From Tables 3.7 and 3.8, the CACGCAG motif is significantly (p = 9.9 x10 -63) 
methylated at a higher proportion in intergenic regions (~70%) as opposed to genic 
regions in both the hyper-virulent and hypo-virulent strains.  
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Table 3.7 Frequency of motifs categorized by the genomic locations in the hyper-
virulent strain 
 Genic* Intergenic 
CTGGAGGA 29 8 
GATNNNNRTAC 120 201 
GTAYNNNNATC 146 146 
CACGCAG 231 563 
*Genes include repeat regions and pseudogenes 
 
Table 3.8 Frequency of motifs categorized by the genomic locations in the hypo-
virulent strain 
 Genic* Intergenic 
GATNNNNRTAC  113 195 
GTAYNNNNATC 109 117 
CACGCAG 222 542 
*Genes include repeat regions and pseudogenes 
 
 
Two out of three predicted motifs are known methyltransferase targets in Type I 
and Type II H37Rv RM systems found in REbase, recently identified using PacBio 
sequencing (Roberts et al. 2010). It is important to classify the m6A based on its 
specific sequence context as each motif is recognised by a methyltransferase 
enzyme which belong to specific classes of RM systems as described below: 
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The CACGCAG motif 
This motif was not found in REbase for H37Rv RM systems, however it was found 
in the M. bovis AN5 genome Type II RM system although the actual cleavage site 
for the restriction enzyme has not been determined. This motif is non-
palindromically methylated. It has also been identified in M. tuberculosis HN878 
Beijing strain as part of the Type II RM system although the actual methylated base 
within the CACGCAG motif was not annotated.  
 
The GATNNNNRTAC/ GTAYNNNNATC motif 
The GATNNNNRTAC/ GTAYNNNNATC motif is the target of a possible Type I: 
subtype Gamma methyltransferase. The cognate restriction enzyme has not been 
identified for this RM system. Type I RM systems consists of a complex comprised 
of three polypeptides which are coded for by the HsdM gene M subunit, DNA 
methyltransferase, the S protein specificity determinant hsdS.1 and the hsdS protein 
(Lew et al. 2011). The S subunit has the same recognition motif as the M subunit. 
These genes have been annotated in Tuberculist as forming the M and S subunits 
which are constituents of the methyltransferase, and methylate the adenine in this 
bi-partite motif in both strands.  
 
The CTGGAGGA motif 
The motif, CTGGAGGA, was identified as unique to the hyper-virulent strain. The 
m6A sites within this motif do not have high confident m6A sites as seen in Table 
3.5. Furthermore, it was identical to the H37Rv type II Restriction Modification 
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system motif, CTGGAG, which was found in REbase, but without the two extra 
bases at the 3’ end.  
 
Shell et al. (2013) identified the similar motif (CTGGAG) to be methylated at the 
same adenine in M. tuberculosis H37RV and Euro-American strains. This site was 
methylated by a methyltransferase encoded for by gene mamA (Shell et al 2013) 
and was shown to be unmethylated at the motif for Beijing HN878 strain due to a 
point mutation in the gene. Their results reveal a 3-fold reduction in adenine 
methylation and attribute the methylation to mamA-independent methylation. Our 
results differ, in that the CTGGAGGA motif is methylated in very few bases only 
in the hyper-virulent strain . Soolingen et al. 1996, also reveal that this motif was 
not methylated in the Beijing lineage. 
 
There were no significant difference in the motifs identified for m4C in both the 
hyper- and hypo-virulent strains.  
 
Motifs characterised in two RM systems according to the REbase database were 
identified. According to REbase these motifs are the target for enzymes from a 
Type II RM system whose principle function in the bacteria immune system is to 
digest foreign DNA. In contrast orphan methyltransferases such as Dam in E.coli 
are not part of RM systems and have functions such as the regulation of virulence 
genes (Davis et al. 2013; Kumar & Rao 2013; Fang et al. 2012). Given that the 
accompanying restriction enzymes were not characterised for M. tuberculosis and 
are not found in REbase, suggesting that the role of methyltransferases in M. 
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tuberculosis might be other than host immunity through restriction modification. 
The methylation sites not occurring within a predicted motif could be due to the 
inaccurate motif prediction from the software. These non-specific m6A sites were 
not identified within a predicted motif due to the ModQv score of 30 which was set 
as the cut off. 
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3.3 Downstream analysis of methylation loci 
 
The downstream analysis of m6A by their genomic regions occurrence has been 
broken down into methylation sites occurring within genes (henceforth termed 
‘genic methylation’) and intergenic regions. In this section, the unique and shared 
approach between hyper-virulent and hypo-virulent strains was employed in 
comparatively analysing the uniquely methylated genomic regions.  
 
3.3.1 Genic Methylation 
 
In this study, genic methylation refers to the methylation positions occurring within 
the following genome features: protein coding sequences, repeat regions, mobile 
elements and pseudogenes.  
 
There is evidence to suggest that genic methylation for m6A and 5mC methylation 
has an effect on gene expression in prokaryotes and eukaryotes but the exact 
mechanism remains unknown (Shenker & Flanagan 2012; Dayeh et al. 2014; 
Kahramanoglou et al. 2012; Furuta et al. 2014). Additionally, there is evidence to 
show that gene expression is mostly affected by methylation in promoter regions 
and noncoding regions (Heithoff 1999; Low et al. 2001). However seeing that a 
considerable number of methyl adenines, 41% and 38% (Table 3.9), for hyper-
virulent and hypo-virulent strains respectively are present in genic regions, it is 
worth discussing them bearing in mind that this would warrant further investigation 
into the exact mechanisms and functional consequences therein and/or thereof.  
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Table 3.9  Summary of methylation sites for intergenic and genic regions, per 
strand, in hyper-virulent and hypo-virulent strains. 
 Hyper-virulent  Hypo-virulent  
 Neg strand Pos strand Neg strand Pos strand 
m6A genic 407 (42%) 375 (39%) 360 (38%) 338 (38%) 
m6A intergenic 577 (58%) 593 (61%) 582 (62%) 550 (62%) 
Total 980 965 939 885 
 
 
Interestingly, the shared sites mostly occur within the predicted motifs while this is 
not the case for the unique sites. 
 
For the m6A positions, a total of 775 and 692 sites overlap in genomic features 
which include CDS and repeat regions and mobile elements for hyper-virulent and 
hypo-virulent strains, respectively. The number of genic m6A positions that are 
uniquely found in the hyper-virulent are 278 (35%) and 195 (27.9%) compared to 
the hypo-virulent strain while 497 sites were shared as outlined in Table 3.10. 
 
 
Table 3.10 Frequency of unique and shared genic and intergenic m6A sites in 
hyper-virulent and hypo-virulent strains and the frequency of methylated genes  
 Genic Methylated genes only Intergenic 
Shared 497 461 897 
Unique hypervirulent 278 213 273 
Unique hypovirulent 195 145 235 
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There were 461 shared methylated genes. In addition, there are 213 and 145 (Table 
3.10) uniquely methylated genes in hyper-virulent and hypo-virulent strains, 
respectively. Given that the number of shared genic positions, at 497, is slightly 
higher than the number of methylated genes (461), multiple methylated sites per 
gene could be as a result of gene overlap. 
 
 
From the 278 unique genic methylation sites in the hyper-virulent strain, only 83 
(29%) occur within a predicted motif. 51 of these sites are in the 
GATNNNNRTAC/GTAYNNNNATC motif, 17 from the CTGGAGGA motif and 
15 from the CACGCAG motif.  
 
For the hypo-virulent strain, out of 195 methylated genic sites, only 7 (3.6%) occur 
in motifs, all 7 of which are the GATNNNNRTAC/GTAYNNNNATC motif. 
 
 
3.3.1.2 Uniquely methylated genes in hyper-virulent and hypo-virulent strains 
 
A functional enrichment of the genes that were uniquely methylated in the hypo-
virulent and hyper-virulent strains, revealed the following COG categories as 
significant: 1) Secondary metabolites biosynthesis, transport and catabolism was 
significantly associated with m6A methylation in the hyper-virulent strain (p = 
0.006), 2) Energy production and conversion (p = 0.015) and 3) Cell 
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wall/membrane/envelope biognesis (p = 0.047) in the hypo-virulent strain. For the 
shared methylated genes between the two strains, no functional categories were 
statistically significant. The enrichment results depicts that methylation has a 
preference for genes of a certain function but does not necessarily mean the non-
enriched genes should be excluded. 
 
Despite the little knowledge of the effects of intragenic methylation and their 
functional consequence, the genic methylation signal reported here is a starting 
point for further investigation into the functional effects in M. tuberculosis.  
 
One plausible explanation for the genic methylation occurrence, is that promoters of 
the adjacent gene could overlap in an open reading frame (ORF) in the previous 
gene as evidenced by (Gonzalez-y-Merchand et al. 1999). Hence, in actual fact it is 
a promoter that is methylated. For example, the outer membrane protein A gene 
OmpA, a methyladenine occurs very close to the end of the gene [position 
1003616]. This is 189 base pairs away from the start of the adjacent gene Rv0901 
[position 1003805] and is close to the end of OmpA [position 1003792] 
implying  that the promoter regions overlaps with OmpA gene (figure 3.1). This is 
expected seeing that bacterial genomes are tightly packed so promoters of genes 
will overlap in an ORF.  
 
In comparison to a study by (Furuta et al. 2014), methylation due to Type I M and S 
genes in H. pylori repressed the expression of genes which contained adenine 
methylation. However, the exact mechanism is yet to be determined. They also 
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identified the CATG motif (Type II RM system) methylated within ORFs and 
found hypermethylation within genes, in particular an RNA polymerase gene 
amongst others whose biological significance could not be determined. Furthermore 
(Lluch-Senar et al. 2013) revealed that adenine  methylation occurring within genes 
did not have a significant effect on gene expression at different growth phases in 
Mycoplasma pneumoniae. Their results also reveal the occurrence of unmethylated 
adenines in the stop codon and hypothesise that these unmethylated sites are 
protected from methylation by an interacting protein.  
 
 
As a functional consequence of genic methylation, it could possibly be that DNA 
methylation interferes with binding of RNA polymerase since the methyl group of 
adenine lowers the thermodynamic stability of DNA, affecting the curvature and 
hence interfering with protein-DNA interactions (Kumar & Rao 2013). The actual 
role of genic methylation is still unclear, hence its biological relevance  cannot be 
explained and will have to be tested in conjunction with experimental 
transcriptomic data to unravel their functional consequences.  
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3.3.2 Intergenic methylation 
 
In this study the intergenic region was defined as any genomic region between gene 
features. The results show that more m6A sites occur within intergenic regions 
which might suggest gene regulation activities of DNA methylation. The hypothesis 
is that DNA methylation occurring in promoters of operons could affect initiation of 
transcription and thereby gene regulation. Therefore, these promoter region 
methyladenines were further examined. Adenine methylation in promoters of 
operons and non-operon genes has been observed in E.coli where the expression of 
pyelone-phritis associated pili operon is regulated by Dam methyltransferase and is 
a critical virulence factor in the upper urinary tract infections (Heithoff 1999). 
 
3.3.2.1 Methylation in promoter regions 
 
A computational approach was employed to examine the methylated promoter 
domains upstream of operons. The hypothesis is that methylation sites overlapping 
within possible promoter binding proteins positions may affect gene expression. 
Genes in an operon are expressed together and are under the same control of one 
head promoter, hence methylation overlap within a promoter region could possibly 
affect transcription and gene expression of these operon genes. To reiterate, the 
promoter region is defined as a 100bp domain upstream from the start of the head 
gene of the operon. 
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As reviewed by (Newton-Foot & Gey van Pittius 2013), the expression of most 
genes in Mycobacterial species is mediated through  regulatory regions situated 
within the upstream intergenic region. Consequently, methylation can lead to up or 
down regulation of a gene (Marinus & Casadesus 2009). Operons form the most 
basic unit of organization in bacterial genomes, and are fundamental in 
understanding transcriptional regulation (Roback et al. 2007). Hence operons 
should be taken into account when analysing the promoter regions. 
 
 
The DOOR software predicted a total of 2341 operons for the H37Rv genome. A 
total of 65 operons in the hyper-virulent strain, whose promoter regions are 
methylated, and 68 operons for the hypo-virulent strain. A total of 20 operon 
promoter regions were found to be uniquely methylated in the hyper-virulent strain 
and 23 for the hypo-virulent strain, while 45 shared methylated operon promoters 
between them. Interestingly, most of the uniquely methylated promoters do not 
have methylation sites occurring in predicted regulatory motifs while the shared 
methylated promoters have predicted regulatory motifs. From the 20 uniquely 
methylated promoters only six have predicted motifs for the hyper-virulent strain. 
While only one promoter contains a predicted motif out of the 23 uniquely 
methylated promoters for the hypo-virulent strain.  
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Intergenic methylation sites occurring in operon promoter regions 
In the hypo-virulent strain, only 68 (10%) of 1132 intergenic sites occur within the 
promoter regions while 67 sites (10%) out of 1170 intergenic sites for the hyper-
virulent strain. The remaining 90% of intergenic sites occur in spacer regions 
between genes of an operon and beyond the defined 100bp promoter region. 
 
The 90% of intergenic methylation not occurring in promoter domains could be due 
to its typical methylation role such as the restriction modification processes or 
maybe playing a role other than gene regulation. Another explanation could be that 
in some cases there could be more complex promoter regions extending up to 1 kb 
from the transcription start sites (Newton-Foot & Gey van Pittius 2013) other than 
the defined 100bp in this study which could account for the 90% intergenic 
methylation.  
 
After identifying the uniquely methylated promoter-associated operon regions 
within the hyper-virulent and hypo-virulent strains, functional enrichment was 
carried out on the operon-associated genes. 
 
 
3.3.2.1.1 Functional enrichment of methylated promoters of operons 
 
All genes belonging to a given methylated promoter-associated operon were 
included in the gene list for the functional enrichment. 
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A total of 36 uniquely methylated promoter associated genes were discovered in 
hyper-virulent (Appendix I) and 32 in hypo-virulent strain (Appendix II) and 68 
shared methylated promoter associated genes (Appendix III). The GO terms and 
COG categories enriched for uniquely and shared methylated operon-associated 
genes for the hyper- and hypo-virulent strains are presented in Tables 3.11 - 3.13. 
 
 
Table 3.11 Significantly enriched functional categories of uniquely methylated 
operon-associated genes in hyper-virulent strain 
Functional category p value 
GO-Growth of symbiont in host cell 0.0 
GO-Response to acid 0.0 
GO-Succinate dehydrogenase activity  0.013 
COG-Energy production and conversion  0.001 
 
 
Table 3.12 Significantly enriched functional categories of uniquely methylated 
operon-associated genes in hypo-virulent strain 
Functional category p value 
GO- Response to zinc ion 0.005 
COG-Function unknown 0.038 
 
 
Response to acid 
The functional categories in Table 3.11 for hyper-virulent strain possibly suggests 
it's adaptation to host environment and stress and subsequent survival of M. 
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tuberculosis in the host. The macrophage phagolysome provides an acidic 
environment hence creating stress on the bacilli and as a means to evade the acidic 
nature of the phagosome M. tuberculosis adjusts its intracellular pH levels to adapt. 
This is also demonstrated in in vitro studies on mutants of acid sensitive M. 
tuberculosis which are attenuated in animal models of infection (Vandal et al. 2009) 
 
Furthermore the deletion of the mymA (Rv3083-Rv3089) operon, whose promoter 
region is found to be methylated in the hyper-virulent strain, is required for growth 
in macrophages and is activated in response to acidic conditions when inside 
macrophages (Cheruvu et al. 2007). Singh et al (2003) have shown that when 
exposed to a low pH the promoter of the mymA operon is induced and the loss of 
this operon resulted in M. tuberculosis failing to persist in spleens of infected 
guinea pigs and showed increased drug sensitivity as well as resulting in death of 
M. tuberculosis due to activated macrophages. This operon promoter was found to 
be uniquely methylated in the hyper-virulent strain suggesting that it plays a key 
role in the adaptation of M. tuberculosis to acidic stress and highlights the possible 
role of DNA methylation in regulating promoter activity in virulence. Additionally, 
the Rv3089 (fadD13) protein was found to be differentially abundant in the hyper-
virulent strain based on proteomic experiments (S. Fortuin personal 
communication). Therefore, the hypothesis could be that methylation in this 
promoter region may have increased transcription of the fadD19 gene. This may 
explain the strategy that M. tuberculosis uses to adapt to acidic stress and 
pathogenesis thereof.  
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Succinate dehydrogenase activity 
The m6A site occurring in the promoter of the Rv0247c-Rv0249c operon does not 
occur in any of the predicted motifs. These genes also belong the tricarboxylic acid 
(TCA) cycle pathway. Interestingly, Rv2048c protein was differentially abundant in 
the hyper-virulent strain (S. Fortuin, personal communication). The GO term 
succinate dehydrogenase (SDH) activity has been significantly enriched in genes 
uniquely methylated in the hyper-virulent strain. According to (Black et al. 2014), 
SDH plays a crucial role in physiological processes such as membrane 
maintenance, hypoxia and ATP synthesis, and could therefore be a potential drug 
target. In M. tuberculosis, the sustained metabolism of succinate through SDH is a 
critical adaptation to hypoxia (Eoh & Rhee 2013). The occurrence of methylation in 
the promoter region, might suggest that these genes are differentially regulated in 
the hyper-virulent strain to possibly ensure survival in hypoxic conditions. 
 
 
Table 3.13 Significantly enriched functional categories of shared methylated 
operon-associated genes in hyper- and hypo-virulent strains 
Functional category p value 
GO- DNA topoisomerase (ATP-hydrolyzing) activity 0.013 
GO- Protein heterodimerization activity 0.002 
 
  
The shared methylated operon-associated genes were enriched for the GO term 
DNA topoisomerase (ATP-hydrolyzing) activity (Table 3.13) with these genes 
playing a role in DNA replication, more specifically in the DNA gyrase operon. The 
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promoter region of this operon is methylated in the Type I motif in both the hyper- 
and hypo-virulent strains which suggests that methylation plays a role in DNA 
replication in M. tuberculosis, similar results have been seen in other bacteria such 
as E.coli and Caulobacter crescentus. Interestingly, the gyrase genes in M. 
tuberculosis are also known drug targets (Mdluli & Ma 2007). 
 
 
Selected operons of interest in the hyper-virulent strain 
Of interest, is the gene Rv2280, coding a possible dehydrogenase involved in 
oxidoreduction, whose promoter region is methylated uniquely within the 
CACGCAG motif. In a study by (Safi et al. 2004), it was demonstrated that in 
H37Rv this gene also has an IS6110 element insert present in the promoter region, 
and has increased gene expression levels. Currently, it is unknow whether 
methylation regulates Rv2280 expression.  
 
The Rv1216c-Rv1219c predicted operon is of special interest. Rv1219c is a 
transcriptional regulator for the other genes within this operon and the methylation 
site overlaps in between the -10 and -35 region upstream of this gene. Our results 
reveal that the GATNNNNRTAC motif, being part of the Type I RM system, is 
methylated upstream of the Rv1219c gene in between the -10 and -35 region. This 
implies that methylation might be directly interfering with transcriptional binding 
proteins, for example an RNA polymerase. Rv1217c and Rv1218c form part of the 
multidrug efflux system ATP-binding cassette (ABC) transporter family and their 
gene expression is controlled by the Rv1219c protein. Furthermore, Rv1217c-
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Rv1218c has been shown to be involved in multidrug antibiotic resistance 
(Balganesh et al. 2010; Wang et al. 2013). Methylation could affect the expression 
of the transcriptional regulator (Rv1219c) which in turn  regulated the expression of 
the efflux pump operon. This suggests a possible link between methylation and drug 
resistance, seeing that this gene is uniquely methylated in the hyper-virulent strain.  
 
 
3.3.2.1.2 Metabolic pathways affected by methylated operon associated 
promoters 
 
To further elucidate the biological relevance, the uniquely methylated promoter  
operon associated genes were mapped to KEGG annotated pathways of the H37Rv 
genome.  
 
A total of 36 uniquely methylated promoter-associated genes were mapped to 19 
pathways in the hyper-virulent strain, and to 15 pathways in the hypo-virulent 
strain. Of these pathways, 10 were unique to the hyper-virulent (Table 3.14) and 5 
to the hypo-virulent strain (Table 3.15).  
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Table 3.14. Strain specific KEGG pathways in hyper-virulent strain 
KO Number Pathway name mtu00363 Bisphenol!degradation mtu00650 Butanoate!metabolism mtu00190 Oxidative!phosphorylation mtu00020 Citrate!cycle!(TCA!cycle) mtu00071 Fatty!acid!degradation mtu00626 Naphthalene!degradation mtu00564 Glycerophospholipid!metabolism mtu00625 Chloroalkane!and!chloroalkene!degradation mtu01220 Degradation!of!aromatic!compounds mtu03420 Nucleotide!excision!repair 
 
 
Table 3.15. Strain specific KEGG pathways in hypo-virulent strain 
KO number Pathway Name 
mtu00260 Glycine,!serine!and!threonine!metabolism 
mtu00760 Nicotinate!and!nicotinamide!metabolism 
mtu00770 Pantothenate!and!CoA!biosynthesis 
mtu03010 Ribosome 
mtu05152 Tuberculosis 
 
 
Energy Conversion and Oxidative phosphorylation 
Oxidative phosphorylation produces ATP which is essential for certain processes in 
replicating persistent bacteria or to promote virulence and survival (Berney & Cook 
 
 
 
 
! 68!
2014; Black et al. 2014). The unique metabolic pathways are involved in the hyper-
virulent strain revealed the oxidative phosphorylation pathway that mycobacteria 
require ATP for replicating in host cells. Along with the fact that energy conversion 
COG category is also enriched might suggest that the hyper-virulent strain may 
require extra ATP and DNA methylation is probably playing a role in driving this 
process. Furthermore, in a study done by our collaborators (S. Fortuin, PhD thesis, 
2013) the hyper-virulent strain showed differentially abundant proteins involved in 
energy metabolism which suggested these genes are up-regulated due to higher 
ATP requirements by the hyper-virulent strain and maybe required for survival and 
adaptation in the host. 
 
 
 
3.3.2.2 Summary 
 
The uniquely methylated regions (21%) in the hyper- and hypo-virulent strains may 
provide insights into their difference in disease phenotypes. Most of the methylation 
positions are shared (79%) between the hyper- and hypo-virulent strains and occur 
in predicted motifs with very few unique methylation positions. The shared 
methylated loci are possibly the regions involved in the typical RM functions of  
bacterial DNA methylation. However, in the case of the bcp gene, the promoter 
region is methylated in both hyper- and hypo-virulent strains and this gene belongs 
to the virulence, detoxification and adaptation category according to Tuberculist 
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(Lew et al. 2011). This implies that DNA methylation might also play a common 
role in expression of certain virulence genes in both the strains.  
 
Promoter DNA methylation in bacteria has been linked to virulence and 
pathogenesis as seen in E. coli, H influenza, Salmonella enterica (Low et al. 2001). 
Our results suggest that the methylation of promoters of certain genes might explain 
the adaptation of the hyper-virulent strain to stress, allowing adaptation to the  
environment and not virulence per se. These genes may possibly be up-regulated or 
down-regulated due to the overlapping of a methylation site with a transcriptional 
regulatory protein site in the promoter region. In some cases, the promoter regions 
in which some methylation sites occur, is within -10 and -35 promoter sequence or 
sigma factor sequences. This may provide the understanding into the mechanism of 
gene expression due to the overlap of a methylated adenine with a sigma factor 
binding site occuring upstream region of Rv0213-Rv0214, as well as the promoter 
region of operon Rv1216c-Rv1219c.  
 
A minor caveat is the absence of annotated transcription start sites for the hyper- 
and hypo-virulent strains with only coordinates of the gene which is not necessarily 
the ORF from which the promoter regions were extrapolated. However about 26% 
of CDSs have leaderless ORFs which contain no UTRs so the gene start is the 
absolute start position of the ORF (Cortes et al. 2013). 
 
A study by (Hemavathy & Nagaraja 1995) showed fairly similar levels of N6 
methyladenine between the virulent H37Rv and avirulent H37Ra M. tuberculosis 
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strains. These findings were based on mass spectrometry but the exact genomic 
positions were not pinpointed and only the methyladenines levels were quantified. 
In parallel, our results generated through the third generation sequencing 
technology reveal that majority of the methyl adenine loci are shared between 
hyper- and hypo-virulent strains. However, the subtle differences in unique 
methylated loci in the hyper-virulent strain might suggest adaptation to survival in 
the host. 
 
Shell et al (2013) reveal that the H37Rv strain had the CTGGAG motif methylated 
in the -10 Sigma factor binding site promoter region, and in response to hypoxia 
certain genes were overexpressed. Similarly, our results indicate that the promoter 
region of certain genes does overlap with adenine methylation sites. The 
methylation sites in promoter regions in M. tuberculosis Beijing strains have not 
been previously characterised using genome-wide single base pair approach with 
PacBio technology. 
 
DNA methylation of certain regulatory regions is thought to play a role in phase 
variation, a remarkable strategy employed by bacteria to rapidly regulate 
transcription in response to environmental stimuli. This allows bacterial pathogens 
such as E. coli to propagate their virulence and to adapt to environmental stimuli in 
the host. Phase variation results in bacterial subpopulations controlled by epigenetic 
mechanisms which result in phenotypic diversity (Casadesús & Low 2013). There 
could be a possibility that M. tuberculosis uses a similar approach to adapt to the 
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environmental stresses in the granuloma, although this hasn’t been experimentally 
confirmed.  
 
Given the different pathogen characteristics and disease phenotypes seen in the 
Beijing family lineages (Aguilar et al. 2010) there is a possibility that DNA 
methylation, specifically adenine methylation, could be a virulence and/or an 
adaptation strategy of M. tuberculosis Beijing sublineage 7 strains in response to 
stress conditions in order to persist infection especially in the hyper-virulent strain. 
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CHAPTER 4: CONCLUSIONS AND FUTURE WORK 
 
The overall aim of this study was to characterise the methylomes of two closely 
related Beijing hyper and hypo-virulent strains with the view of understanding 
virulence. The comparative analysis between hyper and hypo-virulent strains was 
determined by examining the shared and unique methylated genomic regions, which 
might explain their different disease phenotypes.  
 
Using the latest single molecule sequencing technology available and with 
computational analysis, the methylomes for the Beijing sublineage 7 hyper- and 
hypo-virulent strains were identified and characterised. To our knowledge this has 
not been characterised before on a  single base pair resolution for M. tuberculosis.  
 
The exact location of methylated DNA bases was pinpointed, namely N6 
methyladenine and N4 methylcytosine, which even though was described for M. 
tuberculosis using non-sequencing methods, but not its specific location throughout 
the genome. The goals of the thesis have been met whereby the methylation profiles 
and specific positions as well methylated sequence motifs were described for the 
hyper- and hypo-virulent strains. By interrogating the uniquely methylated genomic 
regions in the hyper-virulent strain, intergenic methylated domains of operons were 
identified that may suggest persistence and survival in the  host. In doing so these 
results may provide a starting point into the possible gene regulation functional 
effects that DNA methylation might have in the survival and persistence of 
infection in the hyper-virulent strain. 
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4.1 Key findings  
 
The repertoire of adenine methylation (m6A) was examined within these two strains 
using a comparative approach. Knowledge of these identified methylated genomic 
regions could be used as a molecular typing and/or virulence marker. m6A was 
identified in both strains occurring within the following sequence motifs: 
CACGCAG (Type II RM system), GATNNNNRTAC/GTAYNNNNTC (Type I 
RM system), while the CTGGAGGA motif was found to be uniquely methylated in 
the hyper-virulent strain. Interestingly, the CACGCAG motif was significantly 
methylated at a higher proportion in intergenic regions in both the  hyper- and 
hypo-virulent strains suggesting a role in gene regulation. 
 
The majority (79%) of the methylated positions were shared between the hyper-
virulent and hypo-virulent strains, with very few strain-specific  methylated regions. 
The results in this study indicate that some operons in the hyper-virulent strain, for 
example the mymA operon (response to acid) and the Rv1217c- Rv1218c operon, 
which is a known drug target, have methylated promoter regions, appear to have 
roles in response to stress conditions and not virulence per se.  These have 
implications in the adaptations of M. tuberculosis to stress by possibly using 
methylation occurring in promoter regions as a mechanism to alter gene regulation 
and could be a potential area to investigate since the exact mechanism on gene 
expression has yet to be explored. 
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The PacBio SMRT sequencing employed in this study was proven to be a reliable 
method for DNA methylation detection in M. tuberculosis compared to previous 
unsuccessful attempts using Illumina bisulphite sequencing for detecting 5 
methylcytosine. 
 
4.2 Novel aspects and impact on TB research 
 
A plethora of bacterial methylomes have been recently identified owing to the 
PacBio SMRT technology but to our knowledge none have been determined for the 
medically important M. tuberculosis. DNA methylation of the M. tuberculosis 
genome will change the way we approach the understanding of this pathogen and its 
use as a possible survival mechanism and virulence factor in the host. There are 
several genetic variation studies being undertaken to understand virulence 
mechanisms and pathogenesis, but not DNA methylation-based, with the exception 
of Shell et al (2013), for M. tuberculosis. The computational approach used in this 
thesis opens the doors to understanding M. tuberculosis methylomes. 
 
DNA methylation has not been an extensive area of research in M. tuberculosis and 
has been  poorly described in the literature despite being well characterised along 
with its role in virulence in other pathogenic bacteria such as E.coli.  With the 
findings presented in this thesis, we now have a better understanding of DNA 
methylation patterns in M. tuberculosis and  provides a starting point for in depth 
methylation characterisation of the RM systems in M. tuberculosis. To our 
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knowledge this is the first time M. tuberculosis has been characterised using SMRT 
technology in Beijing strains. 
 
4.3 Limitations  
 
This study used the M. tuberculosis H37Rv genome as the reference strain for 
mapping and identifying the methylated positions hence genomic regions unique to 
the Beijing strains with respect to H37Rv were missed and may possibly contain 
methylated loci. Hence there may be absent methylation loci uniquely occurring in 
the Beijing strains. 
 
These in vitro isolates are snapshots of the hyper and hypo-virulent strains and 
represents a once off representation and not the entire repertoire of DNA 
methylation in every Beijing strain. Thus, additional strains could be sequenced in 
future investigations to achieve a more robust DNA methylation profile and to 
account for the low sequenicng coverage used. Though not the aim of this study, 
what would need to be considered to comprehensively link DNA methylation in 
promoter regions with virulence, is for adenine methylation to be measured over a 
timescale in combination with the corresponding transcriptome and proteome for 
these strains. Despite these limitations this study has definitely revealed novel 
insights into DNA methylation in M. tuberculosis, which has not been well 
characterised previously more especially in Beijing strains given their enhanced 
virulence capacity. 
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One short-coming of this study was the low confidence m4C positions which 
resulted in not proceeding with further downstream analysis. A deeper sequencing 
coverage is therefore recommended to have a clearer picture of the m4C repertoire. 
The m4C signal in the hyper-virulent and hypo-virulent strains appeared to be low 
whereas the m6A signal is more distinct as evidenced by their predicted 
motifs.  These could be false positives and deeper resequencing would be required 
to get highly confident m4C predictions. 
 
4.4 Future work  
 
Comparing the transcriptomes for the two strains to measure the effects of gene 
expression with the overlapping adenine methylation sites predicted in the promoter 
regions in this study could be explored. Additionally, another approach could be to 
measure the virulence attenuation in the identified operons whose promoters were 
methylated. 
 
In conclusion, bacterial methylome discoveries has been a fairly new area of 
research using the latest single molecule sequencing technology. We are only now 
beginning to understand the role of DNA methylation after characterising their 
genomic positions and will require further extensive investigations to understand 
their functional consequences. This thesis provides the basis for the identification 
and characterisation of DNA methylation in M. tuberculosis Beijing strains and the 
novel results presented herein contributes to the largely untapped area of 
mycobacterial epigenetics.  
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